Outcome and prognostic factors of 391 Japanese patients with primary sclerosing cholangitis

Liver International

Volumn 28, Issue 7, 2008, Pages 983-989

  Tanaka, Atsushi ^a   Takamori, Yoriyuki ^a   Toda, Gotaro ^b   Ohnishi, Saburo ^c   Takikawa, Hajime ^a  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

Cholangiocarcinoma; Primary sclerosing cholangitis; Prognostic factors

Indexed keywords

BILIRUBIN; CORTICOSTEROID;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BILE DUCT CARCINOMA; BILIRUBIN BLOOD LEVEL; CANCER INCIDENCE; CONTROLLED STUDY; ENTERITIS; FEMALE; FOLLOW UP; GASTROENTEROLOGY; HUMAN; INDEPENDENT VARIABLE; JAPAN; KAPLAN MEIER METHOD; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; MULTIVARIATE ANALYSIS; OUTCOMES RESEARCH; PANCREATITIS; PRIMARY SCLEROSING CHOLANGITIS; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; QUESTIONNAIRE; SURVIVAL RATE; SURVIVAL TIME;

ADULT; AGED; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; CHOLANGITIS, SCLEROSING; COMORBIDITY; FEMALE; FOLLOW-UP STUDIES; HUMANS; JAPAN; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PROGNOSIS; QUESTIONNAIRES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 47949102139     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2008.01726.x     Document Type: Article

References (22)

1. Mendes F, Lindor K. Primary sclerosing cholangitis. Clin Liver Dis 2004; 8: 195-211.
2. Lindor K, Larusso N. Primary sclerosing cholangitis. In: Schiff ER, et al. eds. Schiff's disease of the liver, 10th edn. Philadelphia: Lippincott Williams & Wilkins, 2007; 673-84.
3. Takikawa H, Manabe T. Primary sclerosing cholangitis in Japan - analysis of 192 cases. J Gastroenterol 1997; 32: 134-7.
4. Takikawa H, Takamori Y, Tanaka A, Kurihara H, Nakanuma Y. Analysis of 388 cases of primary sclerosing cholangitis in Japan. Presence of a subgroup without pancreatic involvement in older patients. Hepatol Res 2004; 29: 153-9.
5. Wiesner R, Grambsch P, Dickson E, et al. Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis. Hepatology 1989; 10: 430-6.
6. Farrant J, Hayllar K, Wilkinson M, et al. Natural history and prognostic variables in primary sclerosing cholangitis. Ganstroenterology 1991; 100: 1710-7.
7. Schrumpf E, Abdelnoor M, Fausa O, Elgjo K, Jenssen E, Kolmannskog F. Risk factors in primary sclerosing cholangitis. J Hepatol 1994; 21: 1061-6.
8. Broome U, Olsson R, Loof L, et al. Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut 1996; 38: 610-5.
9. Kaplan G, Laupland K, Butzner D, Urbanski S, Lee S. The burden of large and small duct primary sclerosing cholangitis in adults and children: A population-based analysis. Am J Gastroenterol 2007; 102: 1042-9.
10. Uehara T, Hamano H, Kawa S, Sano K, Honda T, Ota H. Distinct clinicopathological entity 'autoimmune pancreatitis-associated sclerosing cholangitis'. Pathol Int 2005; 55: 405-11.
11. Kamisawa T, Okamoto A. Autoimmune pancreatitis: Proposal of IgG4-related sclerosing disease. J Gastroenterol 2006; 41: 613-25.
12. Ponsioen C, Vrouenraets S, Prawirodirdjo W, et al. Natural history of primary sclerosing cholangitis and prognostic value of cholangiography in a Dutch population. Gut 2002; 51: 562-6.
13. Tischendorf J, Hecker H, Kruger M, Manns M, Meier P. Characterization, outcome, and prognosis in 273 patients with primary sclerosing cholangitis: A single center study. Am J Gastroenterol 2007; 102: 107-14.
14. Nakanuma Y, Zen Y. Pathology and immunopathology of immunoglobulin G4-related sclerosing cholangitis: The latest addition to the sclerosing cholangitis family. Hepatol Res 2007; Suppl 3: S478-86.
15. Nakazawa T, Ohara H, Sano H, et al. Clinical differences between primary sclerosing cholangitis and sclerosing cholangitis with autoimmune pancreatitis. Pancreas 2005; 30: 20-5.
16. Bergquist A, Glaumann H, Persson B, Broome U. Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: A case-control study. Hepatology 1998; 27: 311-6.
17. Chalasani N, Baluyut A, Ismail A, et al. Cholangiocarcinoma in patients with primary sclerosing cholangitis: A multicenter case-control study. Hepatology 2000; 31: 7-11.
18. Leidenius M, Hockersted K, Broome U, et al. Hepatobiliary carcinoma in primary sclerosing cholangitis: A case control study. J Hepatol 2001; 34: 792-8.
19. Bergquist A, Ekbom A, Olsson R, et al. Hepatic and extrahepatic malignancies in primary sclerosing cholangitis. J Hepatol 2002; 36: 312-27.
20. Burak K, Angulo P, Pasha T, Egan K, Petz J, Lindor K. Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis. Am J Gastroenterol 2004; 99: 523-6.
21. Lazaridis K, Gores G. Primary sclerosing cholangitis and cholangiocarcinoma. Semin Liver Dis 2006; 26: 42-51.
22. Broome U, Lofberg R, Veress B, Eriksson L. Primary sclerosing cholangitis and ulcerative colitis: Evidence for increased neoplastic potential. Hepatology 1995; 22: 1404-8.